ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

SHA:600479 Revenue

ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 948.03M CNY in the quarter ending June 30, 2026, with 16.61% growth. This brings the company's total for the last twelve months to 3.73B, up 5.84% year-over-year. In the year 2025, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B, down -0.03%. That makes ZhuZhou QianJin Pharmaceutical Co.,Ltd the 10,636th largest company in the world by revenue and 1,751st in China.

• Revenue (ttm): 3.73B
• Revenue Growth: +5.84%
• P/S Ratio: 1.43
• Revenue / Employee: 739.76K
• Employees: 5,041
• Market Cap: 5.35B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Drug Production 2.00B 51.0%
• Wholesale and Retail of Pharmaceutical Products 1.55B 39.6%
• Others 222.13M 5.7%
• Production of Chinese Medicinal Materials and Decoction Pieces 148.81M 3.8%

Fiscal year ended Dec 31, 2025 See the full SHA:600479 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.63B	-961.39K	-0.03%
Dec 31, 2024	3.63B	-168.68M	-4.44%
Dec 31, 2023	3.80B	-227.79M	-5.66%
Dec 31, 2022	4.03B	362.43M	9.89%
Dec 31, 2021	3.66B	36.88M	1.02%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error